Targeting the indoleamine 2,3-dioxygenase pathway in cancer

Por Moon, Yong Wha, Hajjar, Joud, Hwu, Patrick, Naing, Aung
Publicado no J Immunother Cancer (2015)

Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent

Por Fu, Siqing, Naing, Aung, Fu, Caroline, Kuo, Macus Tien, Kurzrock, Razelle
Publicado em 2012

Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance

Por Ludwig, Joseph A., Lamhamedi-Cherradi, Salah-Eddine, Lee, Ho-Young, Naing, Aung, Benjamin, Robert
Publicado em 2011

MYB transcription factor isolated from Raphanus sativus enhances anthocyanin accumulation in chrysanthemum cultivars

Por Kee, Eun Sun, Naing, Aung Htay, Lim, Sun Hyung, Han, Jeung Sul, Kim, Chang Kil
Publicado no 3 Biotech (2016)

Phase I Oncology Studies: Evidence That in the Era of Targeted Therapies, Patients on Lower Doses Do Not Fare Worse

Por Jain, Rajul K., Lee, J. Jack, Hong, David, Markman, Maurie, Gong, Jing, Naing, Aung, Wheler, Jennifer, Kurzrock, Razelle
Publicado em 2010

Change in Tumor Size by RECIST Correlates Linearly With Overall Survival in Phase I Oncology Studies

Por Jain, Rajul K., Lee, J. Jack, Ng, Chaan, Hong, David, Gong, Jing, Naing, Aung, Wheler, Jennifer, Kurzrock, Razelle
Publicado em 2012

A pilot study of temsirolimus and body composition

Por Veasey-Rodrigues, Heloisa, Parsons, Henrique A., Janku, Filip, Naing, Aung, Wheler, Jennifer J., Tsimberidou, Apostolia M., Kurzrock, Razelle
Publicado em 2013

Phase I dose-escalating study of TAS-106 in combination with carboplatin in patients with solid tumors

Por Naing, Aung, Fu, Siqing, Zinner, Ralph G., Wheler, Jennifer J., Hong, David S., Arakawa, Kazuhito, Falchook, Gerald S., Kurzrock, Razelle
Publicado em 2013

Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies

Por Jain, Rajul K, Hong, David S, Naing, Aung, Wheler, Jennifer, Helgason, Thorunn, Shi, Nai-Yi, Gad, Yash, Kurzrock, Razelle
Publicado no Cell Cycle (2015)

BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes

Por El-Osta, Hazem, Falchook, Gerald, Tsimberidou, Apostolia, Hong, David, Naing, Aung, Kim, Kevin, Wen, Sijin, Janku, Filip, Kurzrock, Razelle
Publicado em 2011

A Phase I Study of Hepatic Arterial Infusion of Nab-Paclitaxel in Combination with Intravenous Gemcitabine and Bevacizumab for Patients with Advanced Cancers and Predominant Liver...

Por Tsimberidou, Apostolia M., Ye, Yang, Wheler, Jennifer, Naing, Aung, Hong, David, Nwosu, Uchechi, Hess, Kenneth R., Wolff, Robert A.
Publicado em 2013

Phase I Clinical Trials in 85 Patients with Gynecologic Cancer: The M. D. Anderson Cancer Center Experience

Por Moroney, John, Wheler, Jennifer, Hong, David, Naing, Aung, Falchook, Gerald, Bodurka, Diane, Coleman, Robert, Lu, Karen, Xiao, Lianchun, Kurzrock, Razelle
Publicado em 2010

Targeted Morphoproteomic Profiling of Ewing's Sarcoma Treated with Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors: Response/Resistance Signatures

Por Subbiah, Vivek, Naing, Aung, Brown, Robert E., Chen, Helen, Doyle, Laurence, LoRusso, Patricia, Benjamin, Robert, Anderson, Pete, Kurzrock, Razelle
Publicado em 2011

Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience

Por Tsimberidou, Apostolia Maria, Letourneau, Katherine, Wen, Sijin, Wheler, Jennifer, Hong, David, Naing, Aung, Iskander, Nancy G., Uehara, Cynthia, Kurzrock, Razelle
Publicado em 2011

Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors

Por Jiang, Yunyun, Subbiah, Vivek, Janku, Filip, Ludwig, Joseph A., Naing, Aung, Benjamin, Robert S., Brown, Robert E., Anderson, Pete, Kurzrock, Razelle
Publicado em 2014

Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience

Por El-Osta, Hazem, Hong, David, Wheler, Jennifer, Fu, Siqing, Naing, Aung, Falchook, Gerald, Hicks, Marshall, Wen, Sijin, Tsimberidou, Apostolia M., Kurzrock, Razelle
Publicado em 2011

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer: The M. D. Anderson Cancer Center Experience

Por Vaklavas, Christos, Tsimberidou, Apostolia-Maria, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan S., Naing, Aung, Uehara, Cynthia, Wolff, Robert A., Kurzrock, Razelle
Publicado em 2010

Germline PTPRD Mutations in Ewing Sarcoma: Biologic and Clinical Implications

Por Jiang, Yunyun, Janku, Filip, Subbiah, Vivek, Angelo, Laura S., Naing, Aung, Anderson, Peter M., Herzog, Cynthia E., Fu, Siqing, Benjamin, Robert S., Kurzrock, Razelle
Publicado em 2013

PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers

Por Janku, Filip, Lee, J. Jack, Tsimberidou, Apostolia M., Hong, David S., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Luthra, Rajyalakshmi, Garrido-Laguna, Ignacio, Kurzrock, Razelle
Publicado em 2011

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement

Por Tsimberidou, Apostolia M., Letourneau, Katherine, Fu, Siqing, Hong, David, Naing, Aung, Wheler, Jennifer, Uehara, Cynthia, McRae, Stephen E., Wen, Sijin, Kurzrock, Razelle
Publicado em 2010